Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet.
McClung MR, Miller PD, Brown JP, Zanchetta J, Bolognese MA, Benhamou CL, Balske A, Burgio DE, Sarley J, McCullough LK, Recker RR.
McClung MR, et al. Among authors: balske a.
Osteoporos Int. 2012 Jan;23(1):267-76. doi: 10.1007/s00198-011-1791-y. Epub 2011 Sep 27.
Osteoporos Int. 2012.
PMID: 21947137
Free PMC article.
Clinical Trial.